Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$701,222
in 5 filings, $701K under 10b5-1 plans

Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-02 Gibson Christopher Chief Executive Officer Exercise or conversion +31,250 $2.48 $78K 955,734
2023-08-02 Gibson Christopher Chief Executive Officer Sale −60,955 $13.02 $793K 894,779
2023-08-02 Gibson Christopher Chief Executive Officer Sale −4,060 $13.36 $54K 890,719
2023-08-02 Gibson Christopher Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −8,674 407,676
2023-08-02 Gibson Christopher Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −31,250 531,250
2023-07-29 Larson Tina Marriott President and COO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −8,000 532,000
2023-07-27 Larson Tina Marriott President and COO Exercise or conversion 10b5-1 +8,000 $1.06 $8K 432,160
2023-07-27 Larson Tina Marriott President and COO Sale 10b5-1 −3,627 $13.12 $48K 428,533
2023-07-27 Larson Tina Marriott President and COO Sale 10b5-1 −4,373 $14.05 $61K 424,160
2023-07-26 Virani Shafique Chief Business Officer Exercise or conversion 10b5-1 +20,000 $2.22 $44K 163,954
2023-07-26 Virani Shafique Chief Business Officer Sale 10b5-1 −20,000 $14.41 $288K 143,954
2023-07-26 Virani Shafique Chief Business Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −20,000 469,469
2023-07-25 Virani Shafique Chief Business Officer Exercise or conversion 10b5-1 +20,000 $2.22 $44K 163,954
2023-07-25 Virani Shafique Chief Business Officer Sale 10b5-1 −20,000 $14.30 $286K 143,954
2023-07-25 Virani Shafique Chief Business Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −20,000 489,469
2023-07-25 Borgeson Blake Director Sale −18,719 $14.61 $273K 7,487,385
2023-07-20 Gibson Christopher Chief Executive Officer Conversion +10,000 925,810
2023-07-20 Gibson Christopher Chief Executive Officer Gift −10,000 915,810
2023-07-20 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock −10,000 6,531,496
2023-07-19 Secora Michael Chief Financial Officer Exercise or conversion 10b5-1 +37,500 $2.22 $83K 867,913

Page 34 of 41 · 805 trades